Increased expression of hepatic fibroblast growth factor-21 (FGF21), which regulates adiposity, insulin sensitivity, and carbohydrate intake, has been associated with NAFLD (39). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.